Pediatric Injectable Drugs (The Teddy Bear Book)

The Teddy Bear Book is the only reference of its kind that focuses on the unique issues that healthcare professionals face when using injectable medications in children, such as limited fluid volumes, maximum concentrations, and rates of administration. Pediatric Injectable Drugs: The Teddy Bear Book is one of ASHP's most recognized and trusted resources dedicated to providing guidance on the use of injectable medications in children. For more than 20 years, pharmacists, physicians, nurses, and other health professionals have relied on The Teddy Bear Book to provide the most comprehensive research-based information on administering injectable medications to children. The Teddy Bear Book is the only reference of its kind that focuses on the unique issues that healthcare professionals face when using injectable medications in children, such as limited fluid volumes, maximum concentrations, and rates of administration. The 12th edition features more than 4,800 references for 273 updated monographs (including 7 monographs that are new to this edition) that, like previous editions, cover the following areas: Medication error potential Infusion-related cautions Dosages and dose adjustment in organ dysfunction Additives and suitable diluents Maximum concentrations Preparation and delivery Bolus, intermittent, and continuous IV administration Other routes of administration New monographs include: Cysteine Cytomegalovirus immunoglobulin Dalbavancin Difibrotide Ferric derisomaltose Ferrumoxytol Varicella zoster immune globulin New features added to all monographs: Expanded monograph layout Pronunciations Enhanced safety information including ASHP’s Standardize 4 Safety concentration standards, and The KIDs List AHFS® Pharmacologic-Therapeutic Classification© specific category identification

If you work with children, you must have this book. For more than two decades, Pediatric Injectable Drugs (The Teddy Bear Book) has served an important and continuing need for reliable evidence-based information specific to pediatric injectable drugs, including all drugs commonly used in the treatment of infants and children from neonates to adolescents, with age-specific dosing and administration guidelines throughout.ASHP's classic reference on pediatric drugs is now fully revised with the eleventh edition of Pediatric Injectable Drugs. Included in this edition are 15 new monographs, with 241 monographs in total. Each monograph now includes a new category on obesity dosing. All information is compiled in an evidence-based manner from the primary literature, including case reports, observational reports, and comparative trials.As with previous editions, the structure of each of the drug monographs covers the following areas:Brand names.Medication error potential. * Contraindications and warnings.Infusion-related cautions.Age-specific dosage.Dosage adjustment in organ dysfunction.Maximum dosage.Additives.Suitable diluents.Maximum concentrations.Preparation and delivery.IV push.Intermittent infusion.Continuous infusion.Other routes of administration.Comments.When it comes to pediatric injectable drugs, valid safety and efficacy research can be hard to locate: this indispensable reference changes all that.